Saturday, February 27, 2021 5:48:35 PM
Posted byu/cluelessindc 55.5 k MEMBERS r/stocks and Trading on reddit
16 days ago
$MYMX (Mymetics) - Swiss company working on next gen vaccines
Discussion
$MYMX - seems unknown, unloved, unfollowed... it’s of course a risky penny stock. But it’s a real company with some really good brains (and sone funding) leading the charge.
Anyone here follow it? The stock seemed to get some action today. No idea why, but someone on another board cited a NYT article about related vaccine efforts.
Scientists are ramping up research into creating a vaccine that would be effective against all types of corona viruses as new strains have been reported around the world.
(From the yahoo post) In the story Dr. Maria Elena Bottazzi is noted as saying "how she and her team had applied for funding from the U.S. government to produce a universal coronavirus vaccine in 2016 but were rejected. "They said there's no interest in pancorona," Bottazzi told the Times. "It's been a struggle," she added. Apparently now there is a big interest. Also note that Dr. Bottazzi is part of the collaboration between Mymetics and Baylor
https://www.reddit.com/r/StocksAndTrading/comments/lhbd33/mymx_mymetics_swiss_company_working_on_next_gen/
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM